Skip to main content
VA

Valbiotis

La Rochelle, France
Last funding
$9.8M
Post-IPO EquityNov 2022

Valbiotis develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients.

Backed bySofimac Investment Managers

About Valbiotis

How much funding has Valbiotis raised?

Valbiotis has raised $9.8M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2022.

Who are Valbiotis's investors?

Valbiotis's investors include Sofimac Investment Managers.

Where is Valbiotis headquartered?

Valbiotis is headquartered in La Rochelle, France.

What does Valbiotis do?

Valbiotis develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients.

What stage is Valbiotis at?

Valbiotis is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Valbiotis — Funding & Investors." VCBacked, November 8, 2022, https://www.vcbacked.co/company/valbiotis. Accessed November 14, 2026.
APA
VCBacked. (2022). Valbiotis — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/valbiotis
Wikipedia (cite web)
{{cite web |title=Valbiotis — Funding & Investors |url=https://www.vcbacked.co/company/valbiotis |website=VCBacked |access-date=November 14, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Valbiotis? Request a listing update

Founder contacts
m***@valbiotis.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →